News

November 29, 2017November 29, 2017

Older IBD Patients More Likely to Need Surgery and Given Cortisone Treatments Than Younger Ones, Swedish Study Reports

News

Older adults, age 60 or older, with inflammatory bowel disease (IBD) in Sweden are often treated with cortisone medications instead of newer, immune system-targeting therapies, and they are likely to ... Read more

November 28, 2017November 28, 2017

Combining Thiopurine and Anti-TNF Agents Increases Lymphoma Risk in Adults, Study Finds

News

Adult patients with inflammatory bowel disease (IBD) who receive thiopurine monotherapy or anti–tumor necrosis factor (TNF) monotherapy have a higher risk of developing lymphoma when compared to untreated patients, a ... Read more

November 27, 2017November 27, 2017

Progenity Gets $125M in Financing to Speed Development of IBD Diagnostics, Therapeutics Platform

News

Progenity recently closed a $125 million financing round to accelerate development of its gastrointestinal (GI) platform for inflammatory bowel disease (IBD), including precision molecular diagnostic tools, precision therapeutics, microbiome analytics and ... Read more

November 22, 2017

Takeda, Portal Instruments Partner in Developing Needle-free Drug Delivery Service

News

Takeda Pharmaceutical and Portal Instruments will collaborate to develop and commercialize Portal’s needle-free drug delivery service for potential use with Takeda’s investigational and approved therapies, including treatments for ulcerative colitis ... Read more

November 21, 2017

First Patient Enrolls in Phase 2 Trial of ABX464, Potential Ulcerative Colitis Treatment

News

A first patient has been enrolled in a proof-of-concept clinical trial of ABX464 as a possible treatment for people with moderate-to-severe active ulcerative colitis, its developer, Abivax, announced in a press release. The patient ... Read more

November 20, 2017

Eli and Edythe Broad Foundation Awards $1.2 Million to Four UCLA Researchers in IBD

News

Four UCLA researchers conducting early-stage research into inflammatory bowel disease have received four three-year grants totaling $1.2 million from the Eli and Edythe Broad Foundation. The grants bring to more than ... Read more

November 17, 2017November 17, 2017

First RNA-Based Blood Test Available for IBS, IBD Diagnoses, IQuity Announces

News

IQuity, a leading life science technology company in the field of RNA-based diagnosis, announced the release of IsolateIBS-IBD, a pioneering blood test that helps clinicians identify with great accuracy irritable bowel ... Read more

November 16, 2017November 16, 2017

EU Approves Humira Biosimilar Cyltezo for Treatment of Chronic Inflammatory Diseases

News

The European Commission recently approved Cyltezo, a biosimilar to Humira (adalimumab), for the treatment of chronic inflammatory diseases in adults and children including inflammatory bowel diseases (IBDs) such as Crohn’s disease ... Read more

November 15, 2017November 15, 2017

RedHill Biopharma Wraps Up Recruitment for Phase 3 Trial of RHB-104 for Crohn’s

News

RedHill Biopharma has finished recruiting the 331 participants it wanted for a Phase 3 clinical trial of RHB-104 as a treatment for Crohn’s disease. About two-thirds of the participants have already completed the ... Read more

November 14, 2017November 14, 2017

Strict Dietary Changes Help IBD Patients Achieve Clinical Remission in Small Study

News

Researchers have found that eliminating foods known to stimulate intestinal inflammation — a dietary approach known as the autoimmune protocol diet — improves clinical outcomes in inflammatory bowel disease (IBD) ... Read more